LUND, SWEDEN, February 2, 2022 - Oncorena, developing a potential breakthrough therapy for advanced renal cancer, announced today that Professor Börje Haraldsson has joined the Management Team as Chief Scientific Officer effective February 1. Professor Haraldsson,...

read more